FLLL-62

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameFLLL-62
Drug Alias NameFLLL-62
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesThe Ohio State University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A